Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry

Cigall Kadoch wins $250,000 Blavatnik National Award

Cigall Kadoch was named the laureate of the Blavatnik National Awards for Young Scientists in the field of life sciences for her work in cancer biology.

September 20, 2024

Vol.50 No.35

Tumors are able to form with no DNA mutations, fly study shows

Tumors are able to form without any DNA mutations, according to a recent proof-of-principle study performed in flies. Epigenetic changes alone—even temporary alterations—induced permanent cancer cell fate.

Immunotherapy before and after lung cancer surgery reduces death risk, disease recurrence

People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to an analysis by Johns Hopkins Kimmel Cancer Center investigators.

September 13, 2024

Vol.50 No.34

Cancer History Project Conversation with The Cancer Letter

Lung cancer couldn’t slow down physician and athlete Lawrence Phillips

Something odd turned up in one of Lawrence Phillips’s routine health screenings in 2008.

September 06, 2024

Vol.50 No.33

By Deborah Doroshow and McKenzie Prillaman

In Brief

Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor

Laurie H. GlimcherBenjamin Levine EbertLaurie H. Glimcher will step down as Dana-Farber Cancer Institute president and CEO on Oct. 1.

September 06, 2024

Vol.50 No.33

Drugs & Targets

FDA grants Imfinzi priority review and Breakthrough Therapy designation for limited-stage SCLC

FDA granted priority review for Imfinzi (durvalumab), AstraZeneca’s supplemental Biologics License Application, based on the results from the positive ADRIATIC phase III trial in patients with limited-stage small cell lung cancer whose disease has not progressed following platinum-based concurrent chemoradiotherapy.

September 06, 2024

Vol.50 No.33

Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry

YOU MAY BE INTERESTED IN

Cigall Kadoch wins $250,000 Blavatnik National Award

Tumors are able to form with no DNA mutations, fly study shows

Immunotherapy before and after lung cancer surgery reduces death risk, disease recurrence

Lung cancer couldn’t slow down physician and athlete Lawrence Phillips

Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor

FDA grants Imfinzi priority review and Breakthrough Therapy designation for limited-stage SCLC

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login